These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 62062)
21. 5 alpha-reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids. Pham H; Ziboh VA J Steroid Biochem Mol Biol; 2002 Nov; 82(4-5):393-400. PubMed ID: 12589947 [TBL] [Abstract][Full Text] [Related]
22. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer. van der Sluis TM; Meuleman EJ; van Moorselaar RJ; Bui HN; Blankenstein MA; Heijboer AC; Vis AN BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404 [TBL] [Abstract][Full Text] [Related]
23. High serum dihydrotestosterone examined by ultrasensitive LC-MS/MS as a predictor of benign prostatic hyperplasia or Gleason score 6 cancer in men with prostate-specific antigen levels of 3-10 ng/mL. Miyoshi Y; Uemura H; Suzuki K; Shibata Y; Honma S; Harada M; Kubota Y Andrology; 2017 Mar; 5(2):262-267. PubMed ID: 27813361 [TBL] [Abstract][Full Text] [Related]
24. Androgen dynamics in vitro in the normal and hyperplastic human prostate gland. Giorgi EP; Stewart JC; Grant JK; Scott R Biochem J; 1971 Jun; 123(1):41-55. PubMed ID: 4108500 [TBL] [Abstract][Full Text] [Related]
25. Intracellular localisation of 5alpha-dihydrotestosterone in human benign prostatic hypertrophy. Ghanadian R; Chisholm GD; Fotherby K Clin Chim Acta; 1976 Dec; 73(3):521-6. PubMed ID: 63340 [TBL] [Abstract][Full Text] [Related]
26. Correlative study of the morphology and C19-steroid metabolism of benign and cancerous human prostatic tissue. Morfin RF; Leav I; Charles JF; Cavazos LF; Ofner P; Floch HH Cancer; 1977 Apr; 39(4):1517-34. PubMed ID: 856442 [TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment. Guate JL; Escaf S; Menendez CL; del Valle M; Vega JA Urol Int; 1997; 59(3):149-53. PubMed ID: 9428430 [TBL] [Abstract][Full Text] [Related]
28. Secretion of dihydrotestosterone by human prostate in benign prostatic hypertrophy. Mahoudeau JA; Delassalle A; Bricaire H Acta Endocrinol (Copenh); 1974 Oct; 77(2):401-7. PubMed ID: 4138446 [No Abstract] [Full Text] [Related]
29. Dihydrotestosterone concentration in prostate cancer tissue as a predictor of tumor differentiation and hormonal dependency. Geller J; Albert J; de la Vega D; Loza D; Stoeltzing W Cancer Res; 1978 Nov; 38(11 Pt 2):4349-52. PubMed ID: 81107 [TBL] [Abstract][Full Text] [Related]
30. Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume. Pejčić T; Tosti T; Tešić Ž; Milković B; Dragičević D; Kozomara M; Čekerevac M; Džamić Z Prostate; 2017 Jul; 77(10):1082-1092. PubMed ID: 28594074 [TBL] [Abstract][Full Text] [Related]
31. Altered androgen metabolism in carcinoma of the prostate. Ghanadian R; Masters JR; Smith CB Eur Urol; 1981; 7(3):169-70. PubMed ID: 6162644 [TBL] [Abstract][Full Text] [Related]
32. Steroid 5-alpha reductase type 2 activity in biopsies from malignant and normal prostatic tissues. Oliveira OL; Koff WJ; Muraro F; Santos EB; Gomes Soares DF; Trindade VM Clin Chim Acta; 2008 May; 391(1-2):36-40. PubMed ID: 18328817 [TBL] [Abstract][Full Text] [Related]
33. The effect of steroid hormones on the growth pattern and RNA synthesis in human benign prostatic hyperplasia in organ culture. Lasnitzki I; Whitaker RH; Withycombe JF Br J Cancer; 1975 Aug; 32(2):168-78. PubMed ID: 55269 [TBL] [Abstract][Full Text] [Related]
34. Testosterone metabolism in cultured hyperplasia of the human prostate. McMahon MJ; Butler AV; Thomas GH Acta Endocrinol (Copenh); 1974 Dec; 77(4):784-93. PubMed ID: 4139859 [No Abstract] [Full Text] [Related]
35. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer. van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222 [TBL] [Abstract][Full Text] [Related]
36. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. De Marzo AM; Meeker AK; Epstein JI; Coffey DS Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039 [TBL] [Abstract][Full Text] [Related]
37. Characterization and measurement of the androgen receptor in human benign prostatic hyperplasia and prostatic hyperplasia and prostatic carcinoma. Snochowski M; Pousette A; Ekman P; Bression D; Andersson L; Högberg B; Gustafsson JA J Clin Endocrinol Metab; 1977 Nov; 45(5):920-30. PubMed ID: 72758 [No Abstract] [Full Text] [Related]
38. Androgen receptors in benign and malignant prostatic tissue. Lakey WH; Bruchovsky N; Callaway T; Comeau T; Lieskovsky G; Rennie P; Shnitka T; Wilkin P Trans Am Assoc Genitourin Surg; 1979; 71():19-22. PubMed ID: 94714 [TBL] [Abstract][Full Text] [Related]
39. [Measurement of T and DHT contents in normal and diseased human prostate tissues]. Zhang Y; Ye L; Ding Q; Fang Z; Yao M; Shi D Zhonghua Wai Ke Za Zhi; 2000 Jul; 38(7):545-7. PubMed ID: 11832106 [TBL] [Abstract][Full Text] [Related]
40. [Metabolism of 3H-testosteron and 3H-5alpha-DHT in the normal and adenomatous prostate (author's transl)]. Becker H; Klosterhalfen H; Voigt KD Urol Int; 1973; 28(3):350-5. PubMed ID: 4127746 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]